ASIXHIGH SIGNALOPPORTUNITY10-K

ASIX delivered substantially higher revenue growth alongside improved operational efficiency and stronger balance sheet fundamentals.

The company demonstrated exceptional top-line expansion while maintaining disciplined cost management, as evidenced by SG&A expenses growing at a much more modest pace than revenue. The concurrent reduction in total debt and growth in current assets signals improved financial flexibility and operational strength.

Comparing 2026-02-20 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

ASIX posted remarkably strong revenue growth that substantially outpaced the modest increases in operating expenses, contributing to healthy net income improvement of 11.6%. The company strengthened its balance sheet position by reducing total debt by nearly 15% while expanding current assets and inventory levels to support the higher business volumes. The dramatic reduction in share buybacks suggests management is prioritizing debt reduction and operational investment over shareholder returns, reflecting a conservative capital allocation approach during this growth phase.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-84.1%
$10.4M$1.7M

Buyback activity reduced 84.1% — capital being redeployed elsewhere or cash conservation underway.

Revenue
P&L
+45.5%
$1.2B$1.7B

Strong top-line growth of 45.5% — accelerating demand or successful expansion into new markets.

Total Debt
Balance Sheet
-14.8%
$135.0M$115.0M

Debt reduced 14.8% — deleveraging strengthens balance sheet and reduces financial risk.

Current Assets
Balance Sheet
+13.8%
$387.1M$440.6M

Current assets grew 13.8% — improving short-term liquidity or inventory/receivables build.

Net Income
P&L
+11.6%
$44.1M$49.3M

Net income grew 11.6% — bottom-line growth signals improving overall business health.

SG&A Expense
P&L
+11.4%
$94.0M$104.8M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Inventory
Balance Sheet
+11.4%
$212.4M$236.5M

Inventory built 11.4% — monitor whether demand supports this build or if write-downs may follow.

LANGUAGE CHANGES
NEW — 2026-02-20
PRIOR — 2025-02-21
ADDED
There were 26,872,912 shares of common stock outstanding at January 30, 2026.
is an integrated chemistry company that produces essential materials for diverse end markets.
Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets.
Caprolactam Caprolactam is the key monomer used in the production of Nylon 6 resin.
Historical information was reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements.
+7 more — sign up free →
REMOVED
There were 26,744,101 shares of common stock outstanding at January 31, 2025.
is a diversified chemistry company playing a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people s lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics.
Our reliable and sustainable supply of quality products emerges from the integrated value chain of our five U.S.-based manufacturing facilities.
Caprolactam Caprolactam is the key monomer or building block used in the production of Nylon 6 resin.
Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
ABTHIGHAbbott announced a major strategic acquisition of Exact Sciences Corporation to ...
2026-02-20
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →